Moreover, a distinct progression history has been seen in GBM patients, as most secondary GBMs with IDH1 mutations progressed from a WHO Grade II, whereas secondary GBMs lacking IDH1 mutations developed through progression from anaplastic gliomas, WHO Grade III [9]. This evidence concerns the gene IDH1 and grade III glioma.